Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…


THE BUSINESS OF TECHNOLOGY
Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
A brewfest at a baseball stadium is not the most obvious place to discover a vibrant tech ecosystem. But at the OKBio BrewFest earlier this month, at Oklahoma City’s Chickasaw Bricktown Ballpark,…